The first guidance for clinical variant classification in snRNA genes is provided and it is anticipated that this will support routine screening and analysis of snRNA genes in clinical genetic testing.
Abstract
Background: Small nuclear RNAs (snRNAs) are RNA components of the major and minor spliceosomes that play a core role in splice-site recognition and control of the splicing process. Variants in genes that produce snRNAs are increasingly recognised as major contributors to rare disorders, including neurodevelopmental disorders (NDD) and retinal dystrophies (collectively termed RNUopathies, a subset of spliceosomopathies). Clinical interpretation of variants in snRNAs is, however, challenging and existing guidance to support clinical variant classification does not adequately capture the unique features of snRNAs that necessitate a bespoke approach. Methods: We quantified the elevated background mutation rate in snRNA genes using de novo variants from 12,007 trios and assessed mutation density in 76,215 genome sequenced individuals in gnomAD. We convened a panel of clinical, research, and industry scientists with wide-ranging expertise in clinical variant interpretation and classification and expert knowledge in snRNA genes to draft and refine a guidance document. Results: We detail important considerations for variant classification in snRNA genes. These include: the difficulties of variant identification which requires genome or targeted sequencing approaches, the large number of gene paralogs with high sequence identity that complicate read mapping and variant calling, and historical inaccuracies in snRNA gene annotation. Further we show a ~50-fold increase in de novo mutation rate in snRNA genes compared to intergenic sequence and discuss the implications of this for variant classification. We provide a set of specific recommendations for classifying variants in snRNA genes. Finally, we introduce RNUdb, an interactive web-based tool to support snRNA variant annotation and classification. Conclusions: We provide the first guidance for clinical variant classification in snRNA genes and anticipate that this will support routine screening and analysis of snRNA genes in clinical genetic testing.
This review synthesizes the molecular basis of splice-altering variants, current standards for their nomenclature and computational prediction, the practical strengths and limitations of RNA-level validation, and their contribution to epilepsy, hereditary neuropathy, ataxia, dystonia, mitochondrial disease, neuromuscul...
Nishanth Gowda, S. Harish· Neurogenetics· 0 citations
By leveraging specialized approaches for prioritizing pseudogenes, combined with the PCG and snRNA analysis, the genes and variants expand the variant pathogenicity spectrum of spliceosomopathies and suggest variants for follow-up case series and future functional validation.
O. Messaoud, S. DiTroia, R. Tarawneh et al.· medRxiv· 0 citations
A robust RNA biomarker for T-loop ReNU syndrome for use in therapeutic development is defined, and a general framework for portable biomarker discovery in spliceopathies is illustrated.
Ruebena Dawes, A. Blakes, Theodora Markati et al.· medRxiv· 0 citations
It is shown that splice-switching ASOs can elicit target exon skipping and up-regulate endogenous protein levels, and it is shown that TSC1 uORFs act additively to reduce protein translation.
Eloise S. Beer Wells, L. De Conti, Hyung Chul Kim et al.· Genome Medicine· 0 citations
A streamlined minigene-based workflow for rapid functional evaluation of splicing variants and a robust and scalable framework for functional interpretation of splicing variants is developed, improving diagnostic resolution and supporting more informed clinical decision-making in hereditary cancer genetics.
Noemi Calandra, Elisabetta Mereu, P. Ogliara et al.· Journal of Medical Genetics· 0 citations
The Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) research consortium conducted a comprehensive study to characterize spliceogenic variants in BRCA1 exon 18, indicating the degree of splice perturbation required to impair BRCA1 function may depend on the nature of the resulting non-f...
Joanna Domènech-Vivó, Hélène Tubeuf, Romy L. S. Mesman et al.· American Journal of Human Ge...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.